Hideko Suzuki

发表

Mutagenicity of bisphenol A and its suppression by interferon-α in human RSa cells

Shunji Takahashi, K. Kita, S. Sugaya, 2001 .

YKL-40 promotes proliferation of CTCL tumor cells through extracellular signal-regulated kinase pathways.

Shinichi Sato, M. Sugaya, S. Sato, 2020, The Journal of investigative dermatology.

Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T‐cell lymphoma

Shinichi Sato, Y. Asano, M. Sugaya, 2018, The Journal of dermatology.

Hypomutable Potential Accompanying Interferon-α Resistance in a Human Cell Line, IFr, Derived from Interferon-αSensitive and Hypermutable RSa Cells

N. Suzuki, T. Ishizuka, H. Yamamori, 1996 .

Suppression of Saccharin-induced Mutagenicity by Interferon-α in Human RSa Cells

N. Suzuki, Hideko Suzuki, 1995 .

YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal e Regulated Kinase Pathways

M. Sugaya, S. Sato, T. Miyagaki, 2020 .

YKL‐40 augments the proliferation of HaCaT cells via the extracellular regulatory kinase pathway

T. Miyagaki, Hideko Suzuki, S. Sato, 2019, The Journal of dermatology.

SOME SEROLOGICAL PROPERTIES OF HUMAN IMMUNOGLOBULIN PREPARATIONS TREATED WITH β-PROPIOLACTONE

Hideko Suzuki, T. Suzuta, 1976 .

Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis

Y. Asano, M. Sugaya, N. Takahashi, 2017, The Journal of dermatology.

Mutagenicity of saccharin in a human cell strain.

N. Suzuki, H. Suzuki, Hideko Suzuki, 1988, Mutation research.

Detection of K-ras codon 12 mutation by polymerase chain reaction and differential dot-blot hybridization in sodium saccharin-treated human RSA cell.

N. Suzuki, H. Suzuki, Hideko Suzuki, 1993, Biochemical and biophysical research communications.